Pending Approvals-SINOTHERAPEUTICS
    1. 澳门威尼克斯人网站

      c1_bannerpc-691.jpg c1_bannerph-226.jpg

      Launched Drug

      MESALAMINE Delayed Release Tablet
      meishala.png
      • 【Strength】 1.2g
      • 【Approved Regions】: the United Sate

      【Indication】: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis

      For more information, please refer to the manua


      POSACONAZOLE delayed-release tablets
      bosha001-102.jpg
      22.jpg
      33.jpg
      bosha004-804.jpg
      • The first generic drug approved in China and the U.S.
      • A new generation of triazole antifungal drugs
      • 【Approved Regions】:China、 the United States、 Australia、Singapore 、 Saudi Arabia、Canada

      【Strength】100mg

      【Indication】Prophylaxis of invasive Aspergillus and Candida Infections

      For more information, please refer to the manua

      URSODEOXYCHOLIC ACID capsules
      xiongquyang001-50.jpg
      • 【Strength】250mg
      • 【Approved Regions】:China

      【Therapeutic field】Digestive liver and gallbladder

      For more information, please refer to the manua

      BUPROPION HYDROCHLORIDE extended-release tablets
      anfeitatong-384.jpg
      anfei.jpg
      • 【Strength】150 mg, 300 mg
      • 【Approved Regions】:China、 the United States

      【INDICATION】• treatment of major depressive disorder (MDD) • prevention of seasonal affective disorder (SAD)

      For more information, please refer to the manua

      PAROXETINE extended-release tablets
      paluo001-513.jpg
      • 【Strength】12.5mg, 25mg
      • 【Approved Regions】:China、 the United States

      【INDICATION】 Paroxetine extended-release tablets are a selective serotonin reuptake inhibitor (SSRI) indicated in adults for the treatment of : • Major Depressive Disorder (MDD) • Panic Disorder (PD) • Social Anxiety Disorder (SAD)

      For more information, please refer to the manua

      SEVELAMER CARBONATE tablets
      siweilamu001-58.png
      • 【Strength】800mg
      • 【Approved Regions】: the United States

      【Indication】 indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis

      For more information, please refer to the manua


      PROPAFENONE HYDROCHLORIDE extended-release capsules
      puluo1.jpg
      • 【Strength】 225 mg, 325 mg, 425 mg
      • 【Approved Regions】: the United States

      【Indication】Propafenone hydrochloride extended-release capsules is an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.

      For more information, please refer to the manual.

      Pending Approvals

      Shanghai Head Office

      99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China

      Manufacturing Site in Jiangsu

      No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

      Links
      Vastpro
      D-innovation
      qrcode.jpg

      Focus on us

      Copyright © 2014-2022 tongtianty.com ICP:13048014-1   Powered by Yongsy

      Privacy Legal

      友情链接: